Phoenix Molecular Designs
1 clinical trials · Sponsor
◉ Watch Phoenix Molecular Designs
| Record | Firm | Date |
|---|---|---|
| Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer (NCT04115306) | Phoenix Molecular Designs | 2019-11-14 |
Track Phoenix Molecular Designs automatically
Every clearance here is in the API, with alerts when new ones post.